Acquisition strengthens Petauri's medical communications collective, Petauri Advance, with expanded global scale and deep scientific, strategic, and creative expertise

此次收购通过扩大全球规模以及深化科学、战略和创意专业知识，增强了Petauri旗下医疗传播集体“Petauri Advance”的实力。

NASHVILLE, Tenn.

田纳西州纳什维尔

,

，

Nov. 10, 2026

2026年11月10日

/PRNewswire/ -- Petauri, a purpose-built pharmaceutical services platform, today announced the acquisition of

/美通社/ -- 专为制药服务打造的平台Petauri今日宣布收购

Emotive

情感化的

, a global medical communications agency. The acquisition further strengthens the organization's medical communications collective, Petauri Advance, and expands its global reach by adding scientific, strategic, and creative expertise.

，一家全球医疗传播机构。此次收购进一步强化了该组织旗下的医疗传播集体品牌Petauri Advance，并通过引入科学、战略和创意领域的专业能力，拓展其全球影响力。

'As therapies become increasingly complex, our clients need partners that can not only understand the science behind them but translate it for the people who ultimately shape patient care,' said Dan Renick, CEO of Petauri. 'Emotive does just that by bridging scientific precision and industry-recognized creativity to inspire change and help lifesaving treatments reach those who need them most.'.

“随着疗法日益复杂，我们的客户需要的合作伙伴不仅要能理解其背后的科学原理，还要能将这些原理传达给最终影响患者护理的人群，”Petauri 首席执行官 Dan Renick 表示。“Emotive 正是通过融合科学的精准性与业界公认的创造力，激发变革，帮助挽救生命的治疗触达最需要的患者。”

Founded in 2013, Emotive has built a strong reputation for bringing strategic, scientific, and creative thinking to some of healthcare's most complex challenges, with particular depth in neuroscience and immunology, complemented by experience in oncology, rare disease, and other complex areas of medicine.

Emotive 成立于2013年，凭借为医疗保健领域一些最复杂的挑战提供战略性、科学性和创造性思维而建立了良好的声誉，尤其在神经科学和免疫学方面具有深厚的专业积累，并辅以在肿瘤学、罕见病及其他复杂医学领域的丰富经验。

The business will join Petauri Advance's existing strategic medical agencies, DRIVE, PROPEL, MOMENTUM, BluPrint Oncology, Verascity Science, and Cogency. Together, these agencies strengthen Petauri Advance's ability to deliver integrated medical communications spanning strategic planning, insight generation, disease education, promotional communications, publications, and congresses and symposia..

该业务将加入 Petauri Advance 现有的战略医学传播机构组合，包括 DRIVE、PROPEL、MOMENTUM、BluPrint Oncology、Verascity Science 和 Cogency。这些机构共同强化 Petauri Advance 提供整合式医学传播服务的能力，涵盖战略规划、洞察生成、疾病教育、推广传播、学术出版以及会议与研讨会等领域。

'Joining Petauri represents an exciting next chapter for Emotive,' said Chris Edmonds, Founder and CEO of Emotive, who will now serve as Executive Advisor within the organization. 'Emotive was built to turn complex science into communications that inspire meaningful change. Together with Petauri, we can build on that ambition, expanding what we can bring to clients while preserving the partnership they value.'.

“加入Petauri标志着Emotive迈向令人振奋的新篇章，”Emotive创始人兼首席执行官Chris Edmonds表示，他将在该公司担任执行顾问一职。“Emotive的创立宗旨是将复杂的科学转化为能够激发有意义变革的传播内容。通过与Petauri携手合作，我们可以在此基础上进一步拓展，在保留客户珍视的合作伙伴关系的同时，为客户创造更多价值。”

Lisa Hefner, Group President, Petauri Advance, added, 'The strength of this combination lies in the complementary expertise of our teams, our shared core values, and the aligned vision for the future of healthcare communications. Together, our teams bring specialized knowledge across geographies, therapeutic areas, and disciplines to deliver more connected, impactful solutions earlier in the asset life cycle, ultimately helping to improve patient outcomes.'.

Petauri Advance 集团总裁 Lisa Hefner 补充道：“此次合并的优势在于我们团队的专业知识互补、共同的核心价值观，以及对医疗健康传播未来愿景的高度一致。我们的团队携手，在地理区域、治疗领域和专业学科方面提供专业知识，从而在资产生命周期的更早阶段交付更具连贯性和影响力的解决方案，最终帮助改善患者预后。”

Petauri now numbers more than 600 global professionals spanning market access and scientific communications capabilities. In partnership with hundreds of clients, Petauri works to improve patient outcomes by demonstrating the clinical and economic value of innovative medicines and treatments to a wide range of global stakeholders, speeding access to life-changing and often lifesaving medical advances..

Petauri 目前拥有超过 600 名全球专业人士，涵盖市场准入和科学传播能力。通过与数百家客户合作，Petauri 致力于向广泛的全球利益相关者展示创新药物和治疗的临床与经济价值，从而加速改变生命且往往能挽救生命的医疗进展的可及性，最终改善患者预后。

About Petauri

关于 Petauri

Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tennessee. Founded by CEO Dan Renick in partnership with Oak Hill Capital, the platform is launching, acquiring, and combining best-in-class companies with recognized expertise in life sciences, health systems, scientific communications, and market access..

Petauri 是一家总部位于田纳西州纳什维尔、专为制药服务打造的平台。该平台由首席执行官丹·雷尼克（Dan Renick）与橡树山资本（Oak Hill Capital）合作创立，旨在启动、收购并整合在生命科学、医疗体系、科学传播和市场准入领域拥有公认专业知识的行业领先企业。

Since its founding in 2023, the platform has launched Petauri Advisors and acquired The Kinetix Group, the agencies of FORCE Communications, Mtech Access, Delta Hat, the agencies of the Brightly Network, Formulary Insights, Artia Solutions, and Franklin Pharmaceutical Consulting, all now Powered by Petauri™.

自2023年成立以来，该平台已推出Petauri Advisors，并收购了The Kinetix Group、FORCE Communications旗下机构、Mtech Access、Delta Hat、Brightly Network旗下机构、Formulary Insights、Artia Solutions以及Franklin Pharmaceutical Consulting，这些公司现均由Petauri™赋能。

The legacy organizations now comprise Petauri's six business units: Petauri Advance, Petauri Advisors, Petauri Evidence, Petauri Kinect, Petauri MAx, and Artia Solutions. Oak Hill will invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The platform works with pharmaceutical and life sciences clients to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances..

Legacy组织现在包括Petauri的六个业务部门：Petauri Advance、Petauri Advisors、Petauri Evidence、Petauri Kinect、Petauri MAx和Artia Solutions。Oak Hill将从其最新基金（OHCP VI）中投资超过2.5亿美元的股权资本用于这一计划。该平台与制药和生命科学客户合作，通过确立医学进步的科学、经济、人文和社会价值来改善患者治疗效果。

From strategy to implementation, Petauri seamlessly supports these clients with a wide range of innovative solutions that speed patient access to life-changing care. For more information, please visit

从战略到实施，Petauri 通过广泛的创新解决方案无缝支持这些客户，加速患者获得改变生命的治疗。如需更多信息，请访问

www.petauri.com

www.petauri.com

.

。

Media Contact:

媒体联系人：

Liz Gulino

莉兹·古利诺

[email protected]

[email protected]

SOURCE Petauri

来源 Petauri